share_log

海特生物(300683.SZ):上半年净亏损2276.56万元 同比亏损扩大

wuhan hiteck biological pharma (300683.SZ): a net loss of 227.656 million yuan in the first half of the year, with an expanded year-on-year loss.

Gelonghui Finance ·  Aug 26 06:22

Gelonghui, August 26th, Wuhan Hiteck Biological Pharma (300683.SZ) released the semi-annual report for 2024, with a reported half-year revenue of 0.285 billion yuan, a 0.64% decrease year-on-year; a net loss of 22.7656 million yuan attributable to the shareholders of the listed company, the loss expanded year-on-year; the net profit excluding non-recurring gains and losses attributable to the shareholders of the listed company was -47.0363 million yuan; basic earnings per share was -0.17 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment